Cargando…

Improved Cardiovascular and Cardiometabolic Risk in Patients With Type 1 Diabetes and Autoimmune Polyglandular Syndrome Switched From Glargine to Degludec Due to Hypoglycaemic Variability

Background: Cardiovascular disease is a frequent complication of type 1 diabetes (T1D). We evaluated the effectiveness of switching from glargine to degludec in reducing the cardiovascular risk factors, the Framingham risk score (FRS) and visceral adiposity index (VAI) in patients with T1D and autoi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guarnotta, Valentina, Di Bella, Giulia, Pillitteri, Giuseppe, Ciresi, Alessandro, Giordano, Carla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070612/ https://www.ncbi.nlm.nih.gov/pubmed/30093885 http://dx.doi.org/10.3389/fendo.2018.00428

Ejemplares similares

Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis
por: Guarnotta, Valentina, et al.
Publicado: (2018)

Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study
por: Guarnotta, V., et al.
Publicado: (2020)

Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes
por: Predieri, Barbara, et al.
Publicado: (2018)

The Daily Consumption of Cola Can Determine Hypocalcemia: A Case Report of Postsurgical Hypoparathyroidism-Related Hypocalcemia Refractory to Supplemental Therapy with High Doses of Oral Calcium
por: Guarnotta, Valentina, et al.
Publicado: (2017)

Autoimmune polyglandular syndrome type 4: experience from a single reference center
por: Gatta, Elisa, et al.
Publicado: (2023)

Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Yang, Yunjiao, et al.
Publicado: (2022)

Glucose Metabolism in Children With Growth Hormone Deficiency
por: Ciresi, Alessandro, et al.
Publicado: (2018)

Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease Control
por: Ciresi, Alessandro, et al.
Publicado: (2018)

Autoimmune Polyglandular Syndrome Type II: A Case Report
por: Jamal, Hera, et al.
Publicado: (2022)

SAT-071 Autoimmune Polyglandular Syndrome Type 1 with Common Variable Immunodeficiency
por: Shikdar, Yasamen Abdulmannan, et al.
Publicado: (2020)

Serum Thyroid Hormone Antibodies Are Frequent in Patients with Polyglandular Autoimmune Syndrome Type 3, Particularly in Those Who Require Thyroxine Treatment
por: Vita, Roberto, et al.
Publicado: (2017)

Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
por: Kusunoki, Yoshiki, et al.
Publicado: (2013)

Glargine and degludec: Solution behaviour of higher dose synthetic insulins
por: Adams, Gary G., et al.
Publicado: (2017)

The metabolic outcomes of growth hormone treatment in children are gender specific
por: Ciresi, Alessandro, et al.
Publicado: (2018)

Management of Adrenal Deficiency and Shock in a Patient With Polyglandular Autoimmune Syndrome Type II
por: Lantz, Rebekah, et al.
Publicado: (2023)

Safety and Efficacy of Long-Acting Insulins Degludec and Glargine Among Asian Patients With Type 2 Diabetes Mellitus: A Meta-Analysis
por: Kant, Ravi, et al.
Publicado: (2021)

Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment
por: Ferraù, Francesco, et al.
Publicado: (2018)

SAT-242 Pigmented Paravenous Retinochorodial Atrophy: A Novel Manifestation of Autoimmune Polyglandular Syndrome Type 1
por: Zachary, Tyler, et al.
Publicado: (2019)

A Case of Autoimmune Polyglandular Syndrome Type 3b Initially Presenting as Generalized Weakness in an Elderly Patient
por: Ayesh, Hazem, et al.
Publicado: (2021)

Autoimmune Polyglandular Syndrome Type 1
por: Ponranjini, Vedeswari C., et al.
Publicado: (2012)

Autoimmune pancreatitis as a component of autoimmune polyglandular syndrome
por: Piotrowicz, Grażyna, et al.
Publicado: (2016)

More Favorable Metabolic Impact of Three-Times-Weekly versus Daily Growth Hormone Treatment in Naïve GH-Deficient Children
por: Ciresi, Alessandro, et al.
Publicado: (2017)

A Novel Homozygous Mutation of AIRE Gene in a Patient With Autoimmune Polyglandular Syndrome Type I
por: Tautiva-Rojas, Camila M, et al.
Publicado: (2023)

Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report
por: Ciresi, A., et al.
Publicado: (2018)

MON-LB038 Isolated Hypoaldosteronism Due to Autoimmune Adrenalitis in a Patient With Autoimmune Polyglandular Syndrome
por: Grover, Dheera, et al.
Publicado: (2020)

Hepatitis and the polyglandular autoimmune syndrome, type 1
por: Białkowska, Jolanta, et al.
Publicado: (2011)

Hypercalcemia in a patient with autoimmune polyglandular syndrome
por: Katsnelson, Svetlana, et al.
Publicado: (2012)

Autoimmune Polyglandular Syndrome Type 3 with Anorexia
por: Kahara, Toshio, et al.
Publicado: (2012)

Peculiarities of autoimmune polyglandular syndromes in children and adolescents
por: Zirilli, Giuseppina, et al.
Publicado: (2017)

Autoimmune Polyglandular Syndrome Presenting with Jaundice and Thrombocytopenia
por: Norasyikin, A.W., et al.
Publicado: (2014)

Coexistence of Schizophrenia, Epilepsy, and Polyglandular Autoimmune Syndrome
por: Özcan, Halil
Publicado: (2023)

Autoimmune Polyglandular Syndrome with Refractory Gait Disturbance
por: Takeuchi, Yosuke, et al.
Publicado: (2022)

Practical therapeutic approach in the management of diabetes mellitus secondary to Cushing’s syndrome, acromegaly and neuroendocrine tumours
por: Guarnotta, Valentina, et al.
Publicado: (2023)

Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
por: Hartmann, Thorsten, et al.
Publicado: (2016)

Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes
por: Home, P D, et al.
Publicado: (2012)

Polyglandular Autoimmune Syndrome Type III with Primary Hypoparathyroidism
por: Kim, Sang Jin, et al.
Publicado: (2013)

Alopecia Universalis in Polyglandular Autoimmune Syndrome Type I
por: Sardesai, Vidyadhar R, et al.
Publicado: (2013)

SAT-215 A Case of Polyglandular Autoimmune Syndrome
por: Tariq, Sarah
Publicado: (2020)

Multiplex Autoantibody Detection in Patients with Autoimmune Polyglandular Syndromes
por: Savvateeva, Elena N., et al.
Publicado: (2021)

Autoimmune polyglandular syndrome type 2 and recurrent depression
por: Elsayed, Mohamed, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7mlm60a9l8id74jaa4r2r2va9t